Pressure BioSciences, Inc. (OTCQB: PBIOPressure BioSciences, Inc. (OTCQB: PBIO) today announced that the Company will host a teleconference to provide an update on several recent key accomplishments: the acquisition of all assets of BaroFold, the issuance of two patents on the Company’s cutting-edge Ultra Shear Technology (“UST”) platform, and enhancements made to PBI’s core business segment (Research Products & Services). The Company will also offer a brief outlook for the 2018 fiscal year.
Anyone interested may listen to the teleconference either live (by telephone) or through a replay approximately one day after the call (by telephone or via a link on the Company’s website). The replay will be available for at least 30 days thereafter.
All five officers of PBI will be on the call, as will PBI’s Chairman Jeffrey N. Peterson and BaroFold’s former Chairman, Kyle Lefkoff.
The teleconference will include short presentations by the PBI officers as well as comments by our invited guests. Following the remarks, attendees are invited to participate in a question & answer period.
Date: Wednesday, December 20, 2017 – Time: 4:30 PM Eastern Standard Time (EST)
To attend this teleconference live by telephone:
Dial-in: (877) 407-8031 (North America); (201) 689-8031 (International). Verbal Passcode (for the operator): Pressure BioSciences Business Update.
For those unable to participate in the live teleconference, a replay will be available beginning Thursday, December 21, 2017. The replay will be accessible both by telephone and through the Company’s website for at least 30 days.
Replay Numbers: (877) 481-4010 (North America) & (919) 882-2331 (Int’l). Replay ID Number: 23207.
In the interest of full disclosure, we call the reader’s attention to the fact that Equities.com, Inc. is compensated by the companies profiled in the Spotlight Companies section. The purpose of these profiles is to provide awareness of these companies to investors in the micro, small-cap and growth equity community and should not in any way be considered as a recommendation to buy, sell or hold these securities. Equities.com is not a registered broker dealer, investment advisor, financial analyst, investment banker or other investment professional. We are a publisher of original and third party news and information. All profiles are based on information that is available to the public. The information contained herein should not be considered to be complete and is not guaranteed by Equities.com to be free from misstatement or errors. The views expressed are our own and not intended to be the basis for any investment decision. Readers are reminded to do their own due diligence when researching any companies mentioned on this website. Always bear in mind that investing in early-stage companies is risky and you are encouraged to only invest an amount that you can afford to lose completely without any change in your lifestyle. Equities has been compensated with cash, common shares and/or warrants for market awareness services provided.
Read Next
